GORTEC Announces New Trial Success for Head and Neck Cancer Treatment
Press Releases
GORTEC  
January 7, 2025

GORTEC Announces New Trial Success for Head and Neck Cancer Treatment

TOURS, France, Jan. 7, 2025 /PRNewswire/ -- GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol

avatar profile Olean Times Herald

Olean Times Herald


Local & Social